This document introduces the performance of the Agilent microarray platform in the MAQC study.
This document provides an overview of the Microarray Quality Control (MAQC) Consortium study, which evaluated microarray technologies across multiple platforms. The text highlights that the Agilent microarray platform demonstrated superior performance in detecting differentially expressed genes with high accuracy compared to other platforms like Affymetrix and Illumina.
The study involved more than 600 hybridizations across seven platforms.
The ideal result is a value of 1.00 for both concordance and correlation.
The platform uses high-quality 60-mer probes.